Tradition Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Tradition Wealth Management's RXRX Position: Q3 2026 in Review
Tradition Wealth Management reduced its Recursion Pharmaceuticals (RXRX) stake by 7.1% in Q3 2026, selling an estimated $13K and leaving 49,832 shares worth $206K. The position accounts for 0.01% of the portfolio, ranked #505.
Tradition Wealth Management first reported a position in RXRX in Q3 2023 and has held it in 7 quarters since. The position peaked at $272K in Q4 2025. 264 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Tradition Wealth Management held 49,832 shares of Recursion Pharmaceuticals worth $206K as of Q3 2026.
- Tradition Wealth Management sold 3,825 Recursion Pharmaceuticals shares in Q3 2026, an estimated $13K.
- Recursion Pharmaceuticals made up 0.01% of Tradition Wealth Management's portfolio in Q3 2026, its #505 holding.
- Tradition Wealth Management first reported a position in Recursion Pharmaceuticals in Q3 2023 and has held it in 7 quarters since.
- Tradition Wealth Management's Recursion Pharmaceuticals position peaked at $272K in Q4 2025.
- 264 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Tradition Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.